<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665286513750%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904013%26RESULT%3d1%26SIGN%3dlHKDZP7V6MVd6pGO4HeDZ3IWqrM%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904013&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904013&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904013&amp;v=MjM0ODM0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WNzNJUFRYTVpiRzRIOWpNcTQ5RVo0UUtESDg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#46" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#47" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#49" data-title="1.2 方法">1.2 方法</a></li>
                                                <li><a href="#53" data-title="1.3 观察指标">1.3 观察指标</a></li>
                                                <li><a href="#57" data-title="1.4 统计学分析">1.4 统计学分析</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#60" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#61" data-title="2.1 两组患者治疗前后血脂水平比较">2.1 两组患者治疗前后血脂水平比较</a></li>
                                                <li><a href="#63" data-title="2.2 两组患者炎性因子水平比较">2.2 两组患者炎性因子水平比较</a></li>
                                                <li><a href="#69" data-title="2.3 治疗前后患者神经功能缺损评分、Hcy水平比较">2.3 治疗前后患者神经功能缺损评分、Hcy水平比较</a></li>
                                                <li><a href="#73" data-title="2.4 两组患者治疗前后下肢动脉硬化相关指标比较">2.4 两组患者治疗前后下肢动脉硬化相关指标比较</a></li>
                                                <li><a href="#77" data-title="2.5 两组患者不良反应比较">2.5 两组患者不良反应比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#80" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#65" data-title="表1 两组患者治疗前后血脂水平比较 (&lt;image id=&quot;102&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904013_10200.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) ">表1 两组患者治疗前后血脂水平比较 (<image id="102" type="formula" href="images/XXGK201904013_10200.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#67" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组患者炎性因子水平比较&lt;/b&gt; (&lt;image id=&quot;103&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904013_10300.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) "><b>表</b>2 <b>两组患者炎性因子水平比较</b> (<image id="103" type="formula" href="images/XXGK201904013_10300.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#71" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;治疗前后患者神经功能缺损评分、同型半胱氨酸水平比较&lt;/b&gt; (&lt;image id=&quot;104&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904013_10400.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) "><b>表</b>3 <b>治疗前后患者神经功能缺损评分、同型半胱氨酸水平比较</b> (<image id="104" type="formula" href="images/XXGK201904013_10400.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#75" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组患者治疗前后下肢动脉硬化相关指标比较&lt;/b&gt; (&lt;image id=&quot;105&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904013_10500.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s) "><b>表</b>4 <b>两组患者治疗前后下肢动脉硬化相关指标比较</b> (<image id="105" type="formula" href="images/XXGK201904013_10500.jpg" display="inline" placement="inline"><alt></alt></image>±s) </a></li>
                                                <li><a href="#79" data-title="&lt;b&gt;表&lt;/b&gt;5 &lt;b&gt;两组患者不良反应比较&lt;/b&gt;"><b>表</b>5 <b>两组患者不良反应比较</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="张利, 辛佳, 关菲, 等.普罗布考对高同型半胱氨酸血症合并脑梗死患者颈动脉及下肢动脉粥样硬化的疗效观察[J].山西医药杂志, 2017, 46 (11) :1353-1355." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SXYY201711038&amp;v=MDc0MjU3cWZadVptRnlqblY3M0xOalhTZDdHNEg5Yk5ybzlHYklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        张利, 辛佳, 关菲, 等.普罗布考对高同型半胱氨酸血症合并脑梗死患者颈动脉及下肢动脉粥样硬化的疗效观察[J].山西医药杂志, 2017, 46 (11) :1353-1355.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="董晓柳, 徐士军, 张秀清, 等.普罗布考对高同型半胱氨酸血症并轻度认知障碍患者的影响研究[J].实用心脑肺血管病杂志, 2016, 24 (2) :20-23." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYXL201602009&amp;v=MjU4NTJGeWpuVjczTE5qVFRZckc0SDlmTXJZOUZiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        董晓柳, 徐士军, 张秀清, 等.普罗布考对高同型半胱氨酸血症并轻度认知障碍患者的影响研究[J].实用心脑肺血管病杂志, 2016, 24 (2) :20-23.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="Zhang H, Liu Z, Ma S, et al.Ratio of S-adenosylmethionine to S-adenosylhomocysteine as a sensitive indicator of atherosclerosis[J].Mol Medicine Rep, 2016, 14 (1) :289-300." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJSD&amp;filename=SJSD4E620D244C4A1D911B858397186BAB03&amp;v=MjM5NThNOWY4RGxON3FjQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExxN3dxcz1OaWZZYXJmTkdOUE0yNDFCWUpnTGZYMU54aGNTbURkNFFIenJxeA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        Zhang H, Liu Z, Ma S, et al.Ratio of S-adenosylmethionine to S-adenosylhomocysteine as a sensitive indicator of atherosclerosis[J].Mol Medicine Rep, 2016, 14 (1) :289-300.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="张颖, 魏简汇, 翟保同, 等.普罗布考联合依那普利叶酸片对H型高血压患者炎症因子与血浆ET-1的影响[J].重庆医学, 2016, 45 (31) :4418-4420." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201631034&amp;v=MjYxOTlHRnJDVVI3cWZadVptRnlqblY3M0xKanpTZHJHNEg5ZlBybzlHWUlRS0RIODR2UjRUNmo1NE8zenFxQnQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        张颖, 魏简汇, 翟保同, 等.普罗布考联合依那普利叶酸片对H型高血压患者炎症因子与血浆ET-1的影响[J].重庆医学, 2016, 45 (31) :4418-4420.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="董晓柳, 朱丽霞, 徐士军.普罗布考联合瑞舒伐他汀对脑梗死合并糖尿病患者颈动脉粥样硬化斑块、血脂及炎症因子的影响[J].中国动脉硬化杂志, 2016, 24 (2) :177-181." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=KDYZ201602017&amp;v=MDIwMTA1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xMaW5TZExHNEg5Zk1yWTlFWTRRS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        董晓柳, 朱丽霞, 徐士军.普罗布考联合瑞舒伐他汀对脑梗死合并糖尿病患者颈动脉粥样硬化斑块、血脂及炎症因子的影响[J].中国动脉硬化杂志, 2016, 24 (2) :177-181.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="张超, 苗少辉, 董芳.超声波联合普罗布考片对脑梗死患者颈动脉粥样硬化斑块的治疗效果分析[J].检验医学与临床, 2017, 14 (10) :1372-1373." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYYL201710005&amp;v=MzAxMjhIOWJOcjQ5RllZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WNzNMTHpUU1lyRzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        张超, 苗少辉, 董芳.超声波联合普罗布考片对脑梗死患者颈动脉粥样硬化斑块的治疗效果分析[J].检验医学与临床, 2017, 14 (10) :1372-1373.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="Wang T, Li C, Deng W, et al.Influence of Atorvastatin/Probucol Combination on Blood Lipid and Serum C-Reactive Protein Levels in Patients with Cerebral Infarction[J].Tropical Journal of Pharmaceutical Res, 2016, 14 (12) :2313." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Influence of Atorvastatin/Probucol Combination on Blood Lipid and Serum C-Reactive Protein Levels in Patients with Cerebral Infarction">
                                        <b>[7]</b>
                                        Wang T, Li C, Deng W, et al.Influence of Atorvastatin/Probucol Combination on Blood Lipid and Serum C-Reactive Protein Levels in Patients with Cerebral Infarction[J].Tropical Journal of Pharmaceutical Res, 2016, 14 (12) :2313.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="马丽苹, 高义, 王晓鹏.瑞舒伐他汀联合普罗布考对老年脑梗死患者颈动脉粥样硬化、血脂及炎性因子的研究[J].中国循证心血管医学杂志, 2016, 8 (3) :335-338." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201603026&amp;v=MjU1OTlHRnJDVVI3cWZadVptRnlqblY3M0xOVGZUZHJHNEg5Zk1ySTlIWW9RS0RIODR2UjRUNmo1NE8zenFxQnQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        马丽苹, 高义, 王晓鹏.瑞舒伐他汀联合普罗布考对老年脑梗死患者颈动脉粥样硬化、血脂及炎性因子的研究[J].中国循证心血管医学杂志, 2016, 8 (3) :335-338.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="李霞, 周丽, 尹爱良.普罗布考片联合阿托伐他汀钙片与单用阿托伐他汀钙片治疗大动脉粥样硬化型脑梗死临床疗效的对比研究[J].实用心脑肺血管病杂志, 2016, 24 (12) :230-233." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYXL201612018&amp;v=MDk0MTgzTE5qVFRZckc0SDlmTnJZOUViSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        李霞, 周丽, 尹爱良.普罗布考片联合阿托伐他汀钙片与单用阿托伐他汀钙片治疗大动脉粥样硬化型脑梗死临床疗效的对比研究[J].实用心脑肺血管病杂志, 2016, 24 (12) :230-233.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Celer O, Akaloln A, Oztunali C.Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis[J].Clinical Endocrinology (Oxf) , 2016, 85 (4) :556-560." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD6FF463043E0AA16ADC4900FD47D48BB9&amp;v=MjYwMzU9TmlmY2FyWE9hTlhLckk5Qlo1NFBmUTA0eVdkbm1UdDBTSCtVMkJZeURiYWNOOGlXQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExxN3dxcw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Celer O, Akaloln A, Oztunali C.Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis[J].Clinical Endocrinology (Oxf) , 2016, 85 (4) :556-560.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="齐珊珊, 付赵虎, 白炜玮, 等.普罗布考联合阿托伐他汀对大动脉源性脑梗死患者血液黏度、TCD指标及颈动脉斑块稳定性的影响[J].心血管康复医学杂志, 2017, 26 (1) :86-90." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201701023&amp;v=MjYwNTVIWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xQVFhNWmJHNEg5Yk1ybzk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        齐珊珊, 付赵虎, 白炜玮, 等.普罗布考联合阿托伐他汀对大动脉源性脑梗死患者血液黏度、TCD指标及颈动脉斑块稳定性的影响[J].心血管康复医学杂志, 2017, 26 (1) :86-90.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="齐珊珊, 付赵虎, 唐灵涛.普罗布考联合阿托伐他汀治疗大动脉粥样硬化性脑梗死的临床研究[J].现代药物与临床, 2016, 31 (11) :1707-1711." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GWZW201611005&amp;v=MzA0ODFqclJlYkc0SDlmTnJvOUZZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjczTEk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        齐珊珊, 付赵虎, 唐灵涛.普罗布考联合阿托伐他汀治疗大动脉粥样硬化性脑梗死的临床研究[J].现代药物与临床, 2016, 31 (11) :1707-1711.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="马文娟, 杨佳, 赵世刚.普罗布考联合阿托伐他汀对脑梗死患者血清hsCRP ox-LDL MMP-9水平及颈动脉斑块的影响[J].河北医学, 2017, 23 (4) :620-623." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HCYX201704026&amp;v=MTY1OTE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjczTExTN1Nkckc0SDliTXE0OUhZb1FLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        马文娟, 杨佳, 赵世刚.普罗布考联合阿托伐他汀对脑梗死患者血清hsCRP ox-LDL MMP-9水平及颈动脉斑块的影响[J].河北医学, 2017, 23 (4) :620-623.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="Wang BR, Ou Z, Jiang T, et al.Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke due to Large-Artery Atherosclerosis[J].J Stroke Cerebrovasc Dis, 2016, 25 (11) :2746-2751." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke of Large-Artery Atherosclerosis">
                                        <b>[14]</b>
                                        Wang BR, Ou Z, Jiang T, et al.Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke due to Large-Artery Atherosclerosis[J].J Stroke Cerebrovasc Dis, 2016, 25 (11) :2746-2751.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="董晓柳, 张利, 高秋燕, 等.普罗布考对2型糖尿病患者踝肱指数和颈动脉粥样硬化斑块的影响[J].重庆医学, 2016, 45 (31) :4431-4433." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201631040&amp;v=MDUxNzJybzlCWklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xKanpTZHJHNEg5ZlA=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        董晓柳, 张利, 高秋燕, 等.普罗布考对2型糖尿病患者踝肱指数和颈动脉粥样硬化斑块的影响[J].重庆医学, 2016, 45 (31) :4431-4433.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title="Wang R, Wang Y, Mu N, et al.Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice[J].Laboratory Investigation, 2017, 97 (8) :922-934." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Activation of NLRP3 inflammasomes contributes to hyper-homoc ysteinemia aggravated inflammation and atherosclerosis in apoE-deficient mice">
                                        <b>[16]</b>
                                        Wang R, Wang Y, Mu N, et al.Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice[J].Laboratory Investigation, 2017, 97 (8) :922-934.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title="王素艳, 李艳琴.通心络胶囊联合普罗布考治疗缺血性卒中伴颈动脉斑块疗效及对血清ox-LDL、MMP-7、IL-18、IMT的影响[J].现代中西医结合杂志, 2016, 25 (34) :3795-3797." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDJH201634012&amp;v=MTk0MjFyQ1VSN3FmWnVabUZ5am5WNzNMUFNuQlpyRzRIOWZQcTQ5RVpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0Y=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                        王素艳, 李艳琴.通心络胶囊联合普罗布考治疗缺血性卒中伴颈动脉斑块疗效及对血清ox-LDL、MMP-7、IL-18、IMT的影响[J].现代中西医结合杂志, 2016, 25 (34) :3795-3797.
                                    </a>
                                </li>
                                <li id="39">


                                    <a id="bibliography_18" title="张建强, 高红安, 宋程光, 等.普罗布考联合阿司匹林溶解治疗颈动脉斑块脑梗死的临床效果观察[J].现代生物医学进展, 2017, 17 (5) :919-922." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SWCX201705032&amp;v=MDEwOTdvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WNzNMTmpySWRyRzRIOWJNcW85R1o=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[18]</b>
                                        张建强, 高红安, 宋程光, 等.普罗布考联合阿司匹林溶解治疗颈动脉斑块脑梗死的临床效果观察[J].现代生物医学进展, 2017, 17 (5) :919-922.
                                    </a>
                                </li>
                                <li id="41">


                                    <a id="bibliography_19" title="Cioni G, Marcucci R, Gori A M, et al.Increased homocysteine and lipoprotein (a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes[J].J Vasc Surgery, 2016, 64 (1) :163-170." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES2D5F4A975C4C431A051656DD5EA30808&amp;v=MDc2ODBUYnFYQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExxN3dxcz1OaWZPZmJITUc2Zkkzb1pDWVpnTGYzZzZ6bWNUN3o1N1RYbVcyQmRBQ0xHVQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        Cioni G, Marcucci R, Gori A M, et al.Increased homocysteine and lipoprotein (a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes[J].J Vasc Surgery, 2016, 64 (1) :163-170.
                                    </a>
                                </li>
                                <li id="43">


                                    <a id="bibliography_20" title="杨丽, 刘寅, 王树峰, 等.普罗布考联合阿托伐他汀对ACS患者PCI术后ox-LDL及Lp-PLA2水平的影响[J].天津医药, 2017, 45 (1) :47-50." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=TJYZ201701013&amp;v=MDkzMDJmU2RMRzRIOWJNcm85RVo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WNzNMTVM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[20]</b>
                                        杨丽, 刘寅, 王树峰, 等.普罗布考联合阿托伐他汀对ACS患者PCI术后ox-LDL及Lp-PLA2水平的影响[J].天津医药, 2017, 45 (1) :47-50.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),441-445 DOI:10.3969/j.issn.1008-0074.2019.04.13            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>普罗布考在脑梗死合并下肢动脉粥样硬化患者中的疗效及对同型半胱氨酸水平影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%8D%A2%E5%90%9B%E6%85%A7&amp;code=25559055&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">卢君慧</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E6%B9%96%E5%8C%97%E7%9C%81%E8%8D%A3%E5%86%9B%E5%8C%BB%E9%99%A2%E8%8D%A3%E7%96%97%E7%A7%91&amp;code=0139986&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">湖北省荣军医院荣疗科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨普罗布考治疗脑梗死合并下肢动脉粥样硬化患者的疗效以及对同型半胱氨酸 (Hcy) 水平的影响。<b>方法</b>:在我院接受治疗的脑梗死合并下肢动脉粥样硬化患者98例, 随机分为阿托伐他汀组 (48例) 和普罗布考组 (50例) 。治疗1年后, 比较治疗前后血脂、炎性因子、Hcy水平, 神经功能缺损评分、下肢动脉硬化相关指标等变化, 及不良反应发生率。<b>结果</b>:治疗后1年后, 两组患者血脂 (除HDL-C显著升高外) , 炎性因子、Hcy水平及神经功能缺损评分均显著下降, 下肢动脉内膜中层厚度、内膜斑块面积显著减小 (<i>P</i>均=0.001) ;且与阿托伐他汀组比较, 普罗布考组血脂 (除HDL-C显著升高外) 、C反应蛋白[ (11.78±3.02) mg/L比 (8.56±2.45) mg/L]、肿瘤坏死因子α[ (5.23±1.02) ng/L比 (4.02±0.75) ng/L]、中枢神经特异性蛋白 (S100β) [ (0.45±0.10) μg/L比 (0.34±0.09) μg/L]、Hcy [ (16.58±4.19) μmol/L比 (13.25±2.87) μmol/L]水平及神经功能缺损评分[ (8.99±1.35) 分比 (7.12±1.24) 分]均降低更显著, 下肢动脉内膜中层厚度[ (1.50±0.28) mm比 (1.23±0.24) mm]、内膜斑块面积[ (1.35±0.22) cm<sup>2</sup>比 (0.98±0.21) cm<sup>2</sup>]减小更显著 (<i>P</i>均=0.001) 。普罗布考组不良反应发生率显著低于阿托伐他汀组 (10.00%比27.08%, <i>P</i>=0.029) 。<b>结论</b>:普罗布考治疗脑梗死合并下肢动脉粥样硬化患者, 可显著降低患者血脂、炎性因子及同型半胱氨酸水平, 改善下肢动脉粥样硬化及神经功能损伤, 安全有效。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%84%91%E6%A2%97%E6%AD%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">脑梗死;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%8A%A8%E8%84%89%E7%B2%A5%E6%A0%B7%E7%A1%AC%E5%8C%96&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">动脉粥样硬化;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E4%B8%8B%E8%82%A2&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">下肢;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%99%AE%E7%BD%97%E5%B8%83%E8%80%83&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">普罗布考;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-06-21</p>

            </div>
                    <h1>Therapeutic effect of probucol on patients with cerebral infarction complicated lower extremity atherosclerosis and its influence on Hcy level</h1>
                    <h2>
                    <span>LU Jun-hui</span>
            </h2>
                    <h2>
                    <span>Department of Glory Therapy, Hubei Rongjun Hospital</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To explore therapeutic effect of probucol on patients with cerebral infarction (CI) complicated lower extremity atherosclerosis (LEA) and its influence on homocysteine (Hcy) level. <b>Methods</b>:A total of 98 CI + LEA patients treated in our hospital were randomly divided into atorvastatin group (n=48) and probucol group (n=50) , After one year, levels of blood lipids, inflammatory factors and Hcy, score of United States National Institutes of Health Stroke Score (NIHSS) , LEA-related indexes before and after treatment, and incidence of adverse reactions were compared between two groups. <b>Results</b>:Compared with before treatment, after one-year treatment, there were significant reductions in levels of blood lipids (except significant rise in HDL-C) , inflammatory factors and Hcy, NIHSS score, intima-media thickness (IMT) and intimal plaque size of lower extremity arteries in two groups, <i>P</i>=0.001 all. Compared with atorvastatin group after treatment, there were significant reductions in levels of blood lipids (except significant rise in HDL-C level) , C reactive protein [ (11.78±3.02) mg/L vs. (8.56±2.45) mg/L], tumor necrosis factor α [ (5.23±1.02) ng/L vs. (4.02±0.75) ng/L], central nervous system specific protein S100β [ (0.45±0.10) μg/L vs. (0.34±0.09) μg/L], Hcy [ (16.58±4.19) μmol/L vs. (13.25±2.87) μmol/L], NIHSS score [ (8.99±1.35) scores vs. (7.12±1.24) scores], IMT [ (1.50±0.28) mm vs. (1.23±0.24) mm] and intimal plaque size [ (1.35±0.22) cm<sup>2</sup> vs. (0.98±0.21) cm<sup>2</sup>] of lower extremity arteries in probucol group, <i>P</i>=0.001 all. Incidence of adverse reactions within one year in probucol group was significantly lower than that of atorvastatin group (10.00% vs. 27.08%, <i>P</i>=0.029) . <b>Conclusion</b>:Compared with atorvastatin, Probucol can more significantly reduce levels of blood lipids, inflammatory factors and Hcy, improve lower extremity atherosclerosis and neurological function injury in patients with cerebral infarction complicated lower extremity atherosclerosis, and it's safe and effective.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Brain%20infarction&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Brain infarction;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Lower%20extremity&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Lower extremity;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Atherosclerosis&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Atherosclerosis;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Probucol&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Probucol;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-06-21</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="45">脑梗死是临床治疗中常见的脑卒中类型, 因局部脑组织区域血液供应障碍, 导致脑组织缺血缺氧性病变坏死, 发病率、致残率、死亡率极高, 严重威胁人类生命安全<citation id="85" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。研究认为<citation id="86" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>, 导致脑梗死发生的主要原因为下肢动脉粥样硬化, 因此, 稳定下肢动脉粥样硬化是减少脑梗死患者复发和恶化的有效途径, 可降低疾病死亡率、致残率。既往临床主要采用他汀类药物治疗该疾病, 具有降脂和抗炎的效果, 以此来稳定动脉粥样硬化, 但效果不能满足患者的需求, 有待提高<citation id="87" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。资料表明<citation id="88" type="reference"><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>]</sup></citation>, 普罗布考治疗脑梗死合并下肢动脉粥样硬化患者效果显著, 对改善患者临床症状, 促进患者病情好转发挥积极作用。为提高临床治疗脑梗死合并下肢动脉粥样硬化的临床效果, 本次笔者对收治的50例患者给予普罗布考治疗, 观察其治疗效果。现报告如下。</p>
                </div>
                <h3 id="46" name="46" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="47" name="47">1.1 一般资料</h4>
                <div class="p1">
                    <p id="48">选择2015年3月至2016年4月在我院接受治疗的脑梗死合并下肢动脉粥样硬化患者98例, 采用随机数表法分为普罗布考组 (50例) 和阿托伐他汀组 (48例) 。普罗布考组男26例, 女24例, 年龄34～59 (46.89±4.05) 岁;发病至就诊时间2～7 (5.03±0.79) h;阿托伐他汀组男25例, 女23例, 年龄35～59 (46.85±4.12) 岁;发病至就诊时间2～8 (5.02±0.89) h。纳入标准<citation id="89" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>:①患者符合第四届全国脑血管病学术会议修订的诊断标准;②患者经动脉彩超显示存在动脉粥样硬化;③研究经患者家属知晓后签署知情同意书;排除标准:①排除严重器官障碍患者;②排除意识障碍无法进行语言交流的患者;③排除免疫系统、血液系统疾病患者。本研究经过医院伦理委员会批准同意, 患者临床资料比较 (<i>P</i>均&gt;0.05) , 具有可比性。</p>
                </div>
                <h4 class="anchor-tag" id="49" name="49">1.2 方法</h4>
                <div class="p1">
                    <p id="50">两组患者均给予常规β受体阻滞剂、血管紧张素转换酶抑制剂、利尿剂等治疗, 维持酸碱平衡, 监测患者生命体征。</p>
                </div>
                <div class="p1">
                    <p id="51">阿托伐他汀组:给予患者阿托伐他汀 (生产厂家:辉瑞制药股份有限公司;规格:10mg/片;批号:20150421) 治疗。患者于饭后口服阿托伐他汀, 每次口服10mg, 早晚各1次, 连续在服用1年。</p>
                </div>
                <div class="p1">
                    <p id="52">普罗布考组:给予患者普罗布考治疗。患者于饭后口服普罗布考 (生产厂家:宏盛颈复康药业集团有限公司;规格:250mg;批号:20150627) 500mg, 早晚各1次, 连续治疗1年。</p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">1.3 观察指标</h4>
                <div class="p1">
                    <p id="54">比较治疗前、治疗后血清总胆固醇 (TC) 、甘油三酯 (TG) 、低密度脂蛋白-胆固醇 (LDL-C) 、高密度脂蛋白-胆固醇 (HDL-C) 、C反应蛋白 (CRP) 、肿瘤坏死因子α (TNF-α) 、中枢神经特异性蛋白 (S100β) 、同型半胱氨酸 (Hcy) 水平, 神经功能缺损评分、下肢动脉变化, 记录患者恶心呕吐、头晕头痛、过敏反应、肝肾功能异常、胃肠道反应等不良反应发生率。</p>
                </div>
                <div class="p1">
                    <p id="55">抽取患者治疗前、治疗后晨间空腹外周静脉血4ml, 离心处理后, 放置于-45℃冰箱中等待检测, 检测患者TC、TG、LDL-C、HDL-C水平;采用酶联免疫吸附法检测患者TNF-α、CRP、Hcy、S100β水平, 试剂盒由美国MARKET公司提供, 具体操作步骤根据说明书进行;采用超声影像学检查患者下肢动脉情况, 具体包括内膜中层厚度、内膜斑块面积。</p>
                </div>
                <div class="p1">
                    <p id="56">采用美国国立卫生研究院卒中量表对患者神经功能缺损评分进行评价<citation id="90" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>, 患者得分越高, 表明神经功能缺损越严重。</p>
                </div>
                <h4 class="anchor-tag" id="57" name="57">1.4 统计学分析</h4>
                <div class="p1">
                    <p id="58">采用SPSS 19.0分析数据, 计量资料以均数±标准差 (<image id="101" type="formula" href="images/XXGK201904013_10100.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="60" name="60" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="61" name="61">2.1 两组患者治疗前后血脂水平比较</h4>
                <div class="p1">
                    <p id="62">治疗前, 两组患者血脂比较, 差异无统计学意义 (<i>P</i>均&gt;0.05) ;与治疗前比较, 治疗后, 两组患者TC、TG、LDL-C水平均显著降低, HDL-C水平显著升高 (<i>P</i>均=0.001) 。且与阿托伐他汀组比较, 普罗布考组TC、TG、LDL-C水平降低更显著, HDL-C水平升高更显著 (<i>P</i>均=0.001) , 见表1。</p>
                </div>
                <h4 class="anchor-tag" id="63" name="63">2.2 两组患者炎性因子水平比较</h4>
                <div class="p1">
                    <p id="64">治疗前, 两组患者CRP、TNF-α、S100β比较均无显著差异 (<i>P</i>均&gt;0.05) ;治疗后, 两组患者CRP、TNF-α、S100β水平均显著降低, 且普罗布考组显著低于阿托伐他汀组 (<i>P</i>均=0.001) , 见表2。</p>
                </div>
                <div class="area_img" id="65">
                                            <p class="img_tit">
                                                表1 两组患者治疗前后血脂水平比较 (<image id="102" type="formula" href="images/XXGK201904013_10200.jpg" display="inline" placement="inline"><alt></alt></image>±s) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904013_06500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904013_06500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904013_06500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表1 两组患者治疗前后血脂水平比较 (&#177;s)" src="Detail/GetImg?filename=images/XXGK201904013_06500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与阿托伐他汀组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>

                </div>
                <div class="area_img" id="67">
                    <p class="img_tit"><b>表</b>2 <b>两组患者炎性因子水平比较</b> (<image id="103" type="formula" href="images/XXGK201904013_10300.jpg" display="inline" placement="inline"><alt></alt></image>±s)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="67" border="1"><tr><td rowspan="2"><br />组别</td><td colspan="3"><br />C反应蛋白 (mg/L) </td><td colspan="3">肿瘤坏死因子α (ng/L) </td><td colspan="3">中枢神经特异性蛋白S100β (μg/L) </td></tr><tr><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td><td>治疗前</td><td>治疗后</td><td><i>t</i>/<i>P</i></td></tr><tr><td>普罗布考组 (50例) </td><td>15.35±<br />3.23</td><td>8.56±<br />2.45<sup>**△△</sup></td><td>11.688/0.001</td><td>8.56±<br />1.56</td><td>4.02±<br />0.75<sup>**△△</sup></td><td>18.238/0.001</td><td>0.98±<br />0.21</td><td>0.34±<br />0.09<sup>**△△</sup></td><td>19.465/0.001</td></tr><tr><td><br />阿托伐他汀组 (48例) </td><td>15.19±<br />3.24</td><td>11.78±<br />3.02<sup>**</sup></td><td>5.384/0.001</td><td>8.57±<br />1.67</td><td>5.23±<br />1.02<sup>**</sup></td><td>11.888/0.001</td><td>0.93±<br />0.22</td><td>0.45±<br />0.10<sup>**</sup></td><td>13.806/0.001</td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td>0.244/0.807</td><td>5.807/0.001</td><td></td><td>0.030/0.975</td><td>6.709/0.001</td><td></td><td>1.151/0.252</td><td>5.728/0.001</td><td></td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="69" name="69">2.3 治疗前后患者神经功能缺损评分、Hcy水平比较</h4>
                <div class="p1">
                    <p id="70">治疗前, 两组患者神经功能缺损评分、Hcy水平比较均无显著差异 (<i>P</i>均&gt;0.05) ;治疗后, 两组患者神经功能缺损评分、Hcy水平均显著降低, 且普罗布考组显著低于阿托伐他汀组 (<i>P</i>均=0.001) , 见表3。</p>
                </div>
                <div class="area_img" id="71">
                                            <p class="img_tit">
                                                <b>表</b>3 <b>治疗前后患者神经功能缺损评分、同型半胱氨酸水平比较</b> (<image id="104" type="formula" href="images/XXGK201904013_10400.jpg" display="inline" placement="inline"><alt></alt></image>±s) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904013_07100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904013_07100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904013_07100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表3 治疗前后患者神经功能缺损评分、同型半胱氨酸水平比较 (&#177;s)" src="Detail/GetImg?filename=images/XXGK201904013_07100.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>

                </div>
                <h4 class="anchor-tag" id="73" name="73">2.4 两组患者治疗前后下肢动脉硬化相关指标比较</h4>
                <div class="p1">
                    <p id="74">治疗前, 两组患者下肢动脉硬化相关指标比较均无统计学意义 (<i>P</i>均&gt;0.05) ;治疗后, 两组患者内膜中层厚度、内膜斑块面积均显著减小, 且普罗布考组显著小于阿托伐他汀组 (<i>P</i>均=0.001) , 见表4。</p>
                </div>
                <div class="area_img" id="75">
                                            <p class="img_tit">
                                                <b>表</b>4 <b>两组患者治疗前后下肢动脉硬化相关指标比较</b> (<image id="105" type="formula" href="images/XXGK201904013_10500.jpg" display="inline" placement="inline"><alt></alt></image>±s) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904013_07500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904013_07500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904013_07500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表4 两组患者治疗前后下肢动脉硬化相关指标比较 (&#177;s)" src="Detail/GetImg?filename=images/XXGK201904013_07500.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>

                </div>
                <h4 class="anchor-tag" id="77" name="77">2.5 两组患者不良反应比较</h4>
                <div class="p1">
                    <p id="78">治疗期间, 两组患者均有出现恶心呕吐、头晕头痛、过敏反应、肝肾功能异常、胃肠道反应等不良反应, 普罗布考组总发生率10.00%, 显著低于阿托伐他汀组27.08% (<i>P</i>=0.029) , 见表5。</p>
                </div>
                <div class="area_img" id="79">
                    <p class="img_tit"><b>表</b>5 <b>两组患者不良反应比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="79" border="1"><tr><td><br />组别</td><td>例数</td><td>恶心呕吐<br /><i>n</i> (%) </td><td>头晕头痛<br /><i>n</i> (%) </td><td>过敏反应<br /><i>n</i> (%) </td><td>肝、肾功能异常<br /><i>n</i> (%) </td><td>胃肠道反应<br /><i>n</i> (%) </td><td>合计<br /><i>n</i> (%) </td></tr><tr><td><br />普罗布考组</td><td>50</td><td>1 (2.00) </td><td>2 (4.00) </td><td>1 (2.00) </td><td>1 (2.00) </td><td>0 (0.00) </td><td>5 (10.00) <sup>△</sup></td></tr><tr><td><br />阿托伐他汀组</td><td>48</td><td>3 (6.25) </td><td>2 (4.17) </td><td>2 (4.17) </td><td>4 (8.33) </td><td>2 (4.17) </td><td>13 (27.08) </td></tr><tr><td><br /><i>χ</i><sup>2</sup>/<i>P</i></td><td></td><td>0.305/0.580</td><td>0.219/0.639</td><td>0.001/0.971</td><td>0.931/0.334</td><td>0.553/0.457</td><td>4.766/0.029</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="80" name="80" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="81">随着人们饮食结构、生活习惯的改变, 脑梗死疾病的发病率持续增长, 严重威胁患者的生命安全<citation id="91" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。资料表明<citation id="92" type="reference"><link href="19" rel="bibliography" /><link href="21" rel="bibliography" /><sup>[<a class="sup">8</a>,<a class="sup">9</a>]</sup></citation>, 同型半胱氨酸是导致脑梗死出现的独立危险因素, 可通过多种途径损伤机体血管内皮细胞, 刺激平滑肌细胞生长, 最终导致斑块形成, 阻塞血流通路, 破坏凝血机制, 促进血栓形成, 最终诱发脑梗死, 威胁患者生命安全。</p>
                </div>
                <div class="p1">
                    <p id="82">血脂异常是导致脑梗死发病的重要环节, 是诱发动脉粥样硬化形成的主要脂质因素。普罗布考属于一种人工合成的抗氧化剂, 具有调脂、抗氧化、稳定斑块、抗炎以及改善内皮功能的作用, 对改善脑梗死合并下肢动脉粥样硬化疗效显著<citation id="94" type="reference"><link href="23" rel="bibliography" /><link href="25" rel="bibliography" /><sup>[<a class="sup">10</a>,<a class="sup">11</a>]</sup></citation>。本结果证实, 给予患者普罗布考治疗后, 患者血脂下降, 且显著低于采用阿托伐他汀治疗患者, 主要在于:普罗布考通过降低血清胆固醇的合成来调节血清胆固醇的浓度, 阻止细胞对LDL-C的氧化修饰, 有效清除氧自由基, 阻止细胞损伤, 稳定动脉粥样硬化斑块, 改善内皮功能。资料表明<citation id="95" type="reference"><link href="27" rel="bibliography" /><link href="29" rel="bibliography" /><sup>[<a class="sup">12</a>,<a class="sup">13</a>]</sup></citation>, CRP、TNF-α等炎性因子在动脉硬化形成过程中具有始动作用, 可加剧动脉粥样硬化的炎性反应, 降低斑块的稳定性, 加重患者病情, 增加临床治疗难度。而普罗布考可以抑制动脉粥样硬化因子, 降低致炎因子水平以及氧自由基介导的炎性反应, 减少动脉粥样硬化的形成, 缓解患者的临床症状<citation id="93" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。本研究证实, 给予患者普罗布考治疗后, 患者炎性因子水平均降低, 且显著低于采用阿托伐他汀治疗患者, 说明普罗布考可有效调节患者血脂水平, 降低机体炎性因子水平。</p>
                </div>
                <div class="p1">
                    <p id="83">普罗布考被认为是稳定斑块的有效药物之一, 可抑制斑块形成, 改变斑块成分为发挥抗动脉粥样硬化形成作用<citation id="96" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。资料表明<citation id="97" type="reference"><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>, 动脉粥样硬化是导致脑梗死发病的危险因素, 动脉粥样硬化越严重, 患者病情越严重。研究表明<citation id="98" type="reference"><link href="37" rel="bibliography" /><sup>[<a class="sup">17</a>]</sup></citation>, 动脉斑块的形成可导致颈动脉部分或完全堵塞, 导致血管远端血流变得缓慢, 关注下降形成低灌注性梗死, 加重患者病情, 提高脑梗死致残率、死亡率。本研究证实, 给予患者普罗布考干预后, 患者下肢动脉粥样硬化得到有效改善, 且改善效果显著优于采用阿托伐他汀干预患者, 证实普罗布考具有缓解动脉粥样硬化形成的作用。Hcy是导致脑梗死的独立危险因素, 可导致血管舒张功能受损, 促进动脉内膜增厚, 增加黏附性聚集力, 加速血栓形成<citation id="99" type="reference"><link href="39" rel="bibliography" /><sup>[<a class="sup">18</a>]</sup></citation>。而普罗布考能降低Hcy水平, 减少Hcy在血管壁的沉积, 减轻动脉壁损伤, 降低动脉粥样硬化事件的发生风险, 改善机体血脑屏障, 降低血液中S100β水平, 有助于修复神经功能损伤<citation id="100" type="reference"><link href="41" rel="bibliography" /><link href="43" rel="bibliography" /><sup>[<a class="sup">19</a>,<a class="sup">20</a>]</sup></citation>。本研究证实, 普罗布考治疗后, 患者Hcy水平、神经功能缺损评分均显著降低, 且显著低于采用阿托伐他汀治疗患者, 说明普罗布考可降低Hcy水平, 修复受损的神经功能, 缓解患者临床症状。</p>
                </div>
                <div class="p1">
                    <p id="84">综上所述, 给予脑梗死合并下肢动脉粥样硬化患者普罗布考治疗, 可显著降低患者血脂、炎性因子水平, 改善患者下肢动脉粥样硬化及神经功能, 降低Hcy水平, 安全性高, 效果显著。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SXYY201711038&amp;v=MDA0MDNVUjdxZlp1Wm1GeWpuVjczTE5qWFNkN0c0SDliTnJvOUdiSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>张利, 辛佳, 关菲, 等.普罗布考对高同型半胱氨酸血症合并脑梗死患者颈动脉及下肢动脉粥样硬化的疗效观察[J].山西医药杂志, 2017, 46 (11) :1353-1355.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYXL201602009&amp;v=MDY0MTVuVjczTE5qVFRZckc0SDlmTXJZOUZiWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>董晓柳, 徐士军, 张秀清, 等.普罗布考对高同型半胱氨酸血症并轻度认知障碍患者的影响研究[J].实用心脑肺血管病杂志, 2016, 24 (2) :20-23.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJSD&amp;filename=SJSD4E620D244C4A1D911B858397186BAB03&amp;v=MDEzMzFsTjdxY0NPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMcTd3cXM9TmlmWWFyZk5HTlBNMjQxQllKZ0xmWDFOeGhjU21EZDRRSHpycXhNOWY4RA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>Zhang H, Liu Z, Ma S, et al.Ratio of S-adenosylmethionine to S-adenosylhomocysteine as a sensitive indicator of atherosclerosis[J].Mol Medicine Rep, 2016, 14 (1) :289-300.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201631034&amp;v=MTAzNDdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xKanpTZHJHNEg5ZlBybzlHWUlRS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>张颖, 魏简汇, 翟保同, 等.普罗布考联合依那普利叶酸片对H型高血压患者炎症因子与血浆ET-1的影响[J].重庆医学, 2016, 45 (31) :4418-4420.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=KDYZ201602017&amp;v=MTg4MjNVUjdxZlp1Wm1GeWpuVjczTExpblNkTEc0SDlmTXJZOUVZNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>董晓柳, 朱丽霞, 徐士军.普罗布考联合瑞舒伐他汀对脑梗死合并糖尿病患者颈动脉粥样硬化斑块、血脂及炎症因子的影响[J].中国动脉硬化杂志, 2016, 24 (2) :177-181.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=JYYL201710005&amp;v=MTY2MDZxZlp1Wm1GeWpuVjczTEx6VFNZckc0SDliTnI0OUZZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>张超, 苗少辉, 董芳.超声波联合普罗布考片对脑梗死患者颈动脉粥样硬化斑块的治疗效果分析[J].检验医学与临床, 2017, 14 (10) :1372-1373.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Influence of Atorvastatin/Probucol Combination on Blood Lipid and Serum C-Reactive Protein Levels in Patients with Cerebral Infarction">

                                <b>[7]</b>Wang T, Li C, Deng W, et al.Influence of Atorvastatin/Probucol Combination on Blood Lipid and Serum C-Reactive Protein Levels in Patients with Cerebral Infarction[J].Tropical Journal of Pharmaceutical Res, 2016, 14 (12) :2313.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201603026&amp;v=MDY2NjZHNEg5Zk1ySTlIWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xOVGZUZHI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>马丽苹, 高义, 王晓鹏.瑞舒伐他汀联合普罗布考对老年脑梗死患者颈动脉粥样硬化、血脂及炎性因子的研究[J].中国循证心血管医学杂志, 2016, 8 (3) :335-338.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYXL201612018&amp;v=MDkwNTVuVjczTE5qVFRZckc0SDlmTnJZOUViSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>李霞, 周丽, 尹爱良.普罗布考片联合阿托伐他汀钙片与单用阿托伐他汀钙片治疗大动脉粥样硬化型脑梗死临床疗效的对比研究[J].实用心脑肺血管病杂志, 2016, 24 (12) :230-233.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD6FF463043E0AA16ADC4900FD47D48BB9&amp;v=MDQ0ODNIWWZPR1FsZkJyTFUwNXRCaHhMcTd3cXM9TmlmY2FyWE9hTlhLckk5Qlo1NFBmUTA0eVdkbm1UdDBTSCtVMkJZeURiYWNOOGlXQ09OdkZTaVdXcjdKSUZwbWFCdQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Celer O, Akaloln A, Oztunali C.Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis[J].Clinical Endocrinology (Oxf) , 2016, 85 (4) :556-560.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201701023&amp;v=MDM3NDg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjczTFBUWE1aYkc0SDliTXJvOUhaNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>齐珊珊, 付赵虎, 白炜玮, 等.普罗布考联合阿托伐他汀对大动脉源性脑梗死患者血液黏度、TCD指标及颈动脉斑块稳定性的影响[J].心血管康复医学杂志, 2017, 26 (1) :86-90.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=GWZW201611005&amp;v=MjAxNjZHNEg5Zk5ybzlGWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xJanJSZWI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>齐珊珊, 付赵虎, 唐灵涛.普罗布考联合阿托伐他汀治疗大动脉粥样硬化性脑梗死的临床研究[J].现代药物与临床, 2016, 31 (11) :1707-1711.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=HCYX201704026&amp;v=MzIwNjFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblY3M0xMUzdTZHJHNEg5Yk1xNDlIWW9RS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>马文娟, 杨佳, 赵世刚.普罗布考联合阿托伐他汀对脑梗死患者血清hsCRP ox-LDL MMP-9水平及颈动脉斑块的影响[J].河北医学, 2017, 23 (4) :620-623.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke of Large-Artery Atherosclerosis">

                                <b>[14]</b>Wang BR, Ou Z, Jiang T, et al.Independent Correlation of Serum Homocysteine with Cerebral Microbleeds in Patients with Acute Ischemic Stroke due to Large-Artery Atherosclerosis[J].J Stroke Cerebrovasc Dis, 2016, 25 (11) :2746-2751.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=CQYX201631040&amp;v=MDk0NjBGckNVUjdxZlp1Wm1GeWpuVjczTEpqelNkckc0SDlmUHJvOUJaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>董晓柳, 张利, 高秋燕, 等.普罗布考对2型糖尿病患者踝肱指数和颈动脉粥样硬化斑块的影响[J].重庆医学, 2016, 45 (31) :4431-4433.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Activation of NLRP3 inflammasomes contributes to hyper-homoc ysteinemia aggravated inflammation and atherosclerosis in apoE-deficient mice">

                                <b>[16]</b>Wang R, Wang Y, Mu N, et al.Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice[J].Laboratory Investigation, 2017, 97 (8) :922-934.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDJH201634012&amp;v=MjE4Njg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjczTFBTbkJackc0SDlmUHE0OUVab1FLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b>王素艳, 李艳琴.通心络胶囊联合普罗布考治疗缺血性卒中伴颈动脉斑块疗效及对血清ox-LDL、MMP-7、IL-18、IMT的影响[J].现代中西医结合杂志, 2016, 25 (34) :3795-3797.
                            </a>
                        </p>
                        <p id="39">
                            <a id="bibliography_18" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SWCX201705032&amp;v=MTkwMzZab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVjczTE5qcklkckc0SDliTXFvOUc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[18]</b>张建强, 高红安, 宋程光, 等.普罗布考联合阿司匹林溶解治疗颈动脉斑块脑梗死的临床效果观察[J].现代生物医学进展, 2017, 17 (5) :919-922.
                            </a>
                        </p>
                        <p id="41">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES2D5F4A975C4C431A051656DD5EA30808&amp;v=MDg0MzZhQnVIWWZPR1FsZkJyTFUwNXRCaHhMcTd3cXM9TmlmT2ZiSE1HNmZJM29aQ1laZ0xmM2c2em1jVDd6NTdUWG1XMkJkQUNMR1VUYnFYQ09OdkZTaVdXcjdKSUZwbQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>Cioni G, Marcucci R, Gori A M, et al.Increased homocysteine and lipoprotein (a) levels highlight systemic atherosclerotic burden in patients with a history of acute coronary syndromes[J].J Vasc Surgery, 2016, 64 (1) :163-170.
                            </a>
                        </p>
                        <p id="43">
                            <a id="bibliography_20" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=TJYZ201701013&amp;v=MjU1MDJmU2RMRzRIOWJNcm85RVo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WNzNMTVM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[20]</b>杨丽, 刘寅, 王树峰, 等.普罗布考联合阿托伐他汀对ACS患者PCI术后ox-LDL及Lp-PLA2水平的影响[J].天津医药, 2017, 45 (1) :47-50.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904013" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904013&amp;v=MjM0ODM0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WNzNJUFRYTVpiRzRIOWpNcTQ5RVo0UUtESDg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
